How Amgen uses GPT-5

According to the OpenAI Blog, Amgen, a leading biotechnology company, has integrated GPT-5 into its research and development pipeline. While specific applications are not detailed in the snippet, the adoption highlights how large language models are being tailored for scientific discovery, particularly in drug development and genomic analysis. For AI workflow builders, this signals a growing trend where general-purpose models are fine-tuned for specialized domains—moving beyond chatbots into critical R&D environments. The practical takeaway: expect more enterprises to leverage LLMs for data-heavy tasks like protein structure prediction, literature mining, and hypothesis generation. This case underscores the need for robust model customization, data privacy measures, and validation protocols when deploying AI in regulated industries.